SCHEMBL8430807

SCHEMBL8430807

N=C(N)Nc1cccc(OC(=O)[C@H](Cc2ccccc2)N(NC=O)S(=O)(=O)c2cc(Cl)cc(Cl)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
LTA4H P09960 1/20 0.33
CACNA1H O95180 4/20 0.33
RAB9A P51151 1/20 0.33
PTGES O14684 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
ADAMTS5 Q9UNA0 1/20 0.33
CYP2C8 P10632 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
ADRA2B P18089 1/20 0.32
HTR2C P28335 1/20 0.32
P2RX3 P56373 1/20 0.32
SLC6A3 Q01959 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430878 0.93 CA12 (0.39) CA12CA1CA2CA9LTA4H
SCHEMBL8429288 0.87 CA2 (0.38) CA12CA1CA2CA9LTA4H
SCHEMBL8432878 0.85 ITGB3 (0.39) CA12CA1CA2CA9RAB9A
SCHEMBL8429051 0.83 SIRT2 (0.36) CA12CA1CA2CA9LTA4H
SCHEMBL8431173 0.82 CTSD (0.35) CA12CA1CA2CA9LTA4H
SCHEMBL8432438 0.80 RAB9A (0.37) CA12CA1CA2CA9LTA4H
SCHEMBL8431432 0.79 RAB9A (0.36) CA12CA1CA2CA9LTA4H
SCHEMBL8431230 0.79 RAB9A (0.40) CA12CA1CA2CA9LTA4H
SCHEMBL8431034 0.77 ALDH1A1 (0.41) LTA4HRAB9ALMNATP53MAPT
SCHEMBL8430957 0.77 PLAU (0.38) LTA4HRAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed